Amgen to Cut 350 Horizon Employees After Closing Purchase

Amgen Inc. will lay off 350 employees from Horizon Therapeutics Plc next year, after closing its $27.8 billion acquisition of the rare-disease drugmaker earlier this month.

More than 80% of Horizon employees were placed in roles at Amgen, according to an email from Jessica Akopyan, a spokesperson for the biotechnology company. None of the laid-off employees have separation dates this year and all cuts would be in the US or Ireland, she said.

Amgen has about 26,700 staff worldwide following the Horizon acquisition, Akopyan said. The company made “changes where we had redundancies in roles or needed to pivot priorities,” ...